Company intelligence / Profile preview

Rincon Bio

Salt Lake City, Utah, United Statesrinconbio.com ↗

Ownership: Private
Development stage: Other

Overview

Rincon Bio specializes in conducting pre-clinical in vivo efficacy studies using both xenograft and syngeneic animal models to support oncology and immuno-oncology drug development. The company does not develop its own therapeutics but supports biopharma clients with rapid initiation of studies and competitive pricing.

Therapeutic areas: Oncology
Modalities: Cell line xenograft modelsSyngeneic mouse modelsImmuno-oncology model systems
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Rincon Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rincon Bio.

Explore the full profile